MedTrace Logo

Time Course of Circulating Myocardial Biomarkers After a TASH Procedure.

NCT03648736 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2020-03-12

No results posted yet for this study

Summary

The study evaluates the released myocardial substances in blood of HOCM patients after TASH procedure (small "controlled" myocardial infarction). This helps to identify new pathomechanisms and biomarker and thus provides a better understanding of development and progress of cardiac insufficiency.

Conditions

  • Cardiac Insufficiency

Interventions

OTHER

blood withdrawal

* peripheral-venous before TASH, day 1, 2, 3, one week and one month after TASH procedure * central-venous during TASH

Sponsors & Collaborators

  • RWTH Aachen University

    lead OTHER

Principal Investigators

  • Robert Stöhr, Dr. med. · RWTH Aachen University, Aachen University Hospital, Medical Clinic I

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-10-10
Primary Completion
2021-05-31
Completion
2021-05-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03648736 on ClinicalTrials.gov